1 Small Molecule Active Pharmaceutical Ingredient Market Overview 1.1 Product Overview and Scope of Small Molecule Active Pharmaceutical Ingredient 1.2 Small Molecule Active Pharmaceutical Ingredient Segment by Type 1.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Standard API 1.2.3 High Potency API 1.3 Small Molecule Active Pharmaceutical Ingredient Segment by Application 1.3.1 Small Molecule Active Pharmaceutical Ingredient Sales Comparison by Application: (2021-2027) 1.3.2 Cardiovascular Diseases 1.3.3 Respiratory Disorders 1.3.4 Infectious Diseases 1.3.5 Others 1.4 Global Small Molecule Active Pharmaceutical Ingredient Market Size Estimates and Forecasts 1.4.1 Global Small Molecule Active Pharmaceutical Ingredient Revenue 2016-2027 1.4.2 Global Small Molecule Active Pharmaceutical Ingredient Sales 2016-2027 1.4.3 Small Molecule Active Pharmaceutical Ingredient Market Size by Region: 2016 Versus 2021 Versus 2027 2 Small Molecule Active Pharmaceutical Ingredient Market Competition by Manufacturers 2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Manufacturers (2016-2021) 2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Small Molecule Active Pharmaceutical Ingredient Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Small Molecule Active Pharmaceutical Ingredient Manufacturing Sites, Area Served, Product Type 2.5 Small Molecule Active Pharmaceutical Ingredient Market Competitive Situation and Trends 2.5.1 Small Molecule Active Pharmaceutical Ingredient Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Small Molecule Active Pharmaceutical Ingredient Players Market Share by Revenue 2.5.3 Global Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Small Molecule Active Pharmaceutical Ingredient Retrospective Market Scenario by Region 3.1 Global Small Molecule Active Pharmaceutical Ingredient Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Small Molecule Active Pharmaceutical Ingredient Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country 3.3.1 North America Small Molecule Active Pharmaceutical Ingredient Sales by Country 3.3.2 North America Small Molecule Active Pharmaceutical Ingredient Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country 3.4.1 Europe Small Molecule Active Pharmaceutical Ingredient Sales by Country 3.4.2 Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Region 3.5.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Region 3.5.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country 3.6.1 Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Country 3.6.2 Latin America Small Molecule Active Pharmaceutical Ingredient Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country 3.7.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Country 3.7.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Small Molecule Active Pharmaceutical Ingredient Historic Market Analysis by Type 4.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2021) 4.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Type (2016-2021) 4.3 Global Small Molecule Active Pharmaceutical Ingredient Price by Type (2016-2021) 5 Global Small Molecule Active Pharmaceutical Ingredient Historic Market Analysis by Application 5.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2021) 5.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Application (2016-2021) 5.3 Global Small Molecule Active Pharmaceutical Ingredient Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Johnson Matthey 6.1.1 Johnson Matthey Corporation Information 6.1.2 Johnson Matthey Description and Business Overview 6.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Johnson Matthey Product Portfolio 6.1.5 Johnson Matthey Recent Developments/Updates 6.2 Siegfried Holding AG 6.2.1 Siegfried Holding AG Corporation Information 6.2.2 Siegfried Holding AG Description and Business Overview 6.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Siegfried Holding AG Product Portfolio 6.2.5 Siegfried Holding AG Recent Developments/Updates 6.3 Pfizer 6.3.1 Pfizer Corporation Information 6.3.2 Pfizer Description and Business Overview 6.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Pfizer Product Portfolio 6.3.5 Pfizer Recent Developments/Updates 6.4 Sanofi S.A. 6.4.1 Sanofi S.A. Corporation Information 6.4.2 Sanofi S.A. Description and Business Overview 6.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sanofi S.A. Product Portfolio 6.4.5 Sanofi S.A. Recent Developments/Updates 6.5 Novartis AG, 6.5.1 Novartis AG, Corporation Information 6.5.2 Novartis AG, Description and Business Overview 6.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Novartis AG, Product Portfolio 6.5.5 Novartis AG, Recent Developments/Updates 6.6 Bristol-Myers Squibb 6.6.1 Bristol-Myers Squibb Corporation Information 6.6.2 Bristol-Myers Squibb Description and Business Overview 6.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Bristol-Myers Squibb Product Portfolio 6.6.5 Bristol-Myers Squibb Recent Developments/Updates 6.7 Boehringer Ingelheim GmbH 6.6.1 Boehringer Ingelheim GmbH Corporation Information 6.6.2 Boehringer Ingelheim GmbH Description and Business Overview 6.6.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Boehringer Ingelheim GmbH Product Portfolio 6.7.5 Boehringer Ingelheim GmbH Recent Developments/Updates 6.8 GlaxoSmithKline 6.8.1 GlaxoSmithKline Corporation Information 6.8.2 GlaxoSmithKline Description and Business Overview 6.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.8.4 GlaxoSmithKline Product Portfolio 6.8.5 GlaxoSmithKline Recent Developments/Updates 6.9 Albany Molecular Research Inc. 6.9.1 Albany Molecular Research Inc. Corporation Information 6.9.2 Albany Molecular Research Inc. Description and Business Overview 6.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Albany Molecular Research Inc. Product Portfolio 6.9.5 Albany Molecular Research Inc. Recent Developments/Updates 6.10 Bachem Holding AG 6.10.1 Bachem Holding AG Corporation Information 6.10.2 Bachem Holding AG Description and Business Overview 6.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Bachem Holding AG Product Portfolio 6.10.5 Bachem Holding AG Recent Developments/Updates 6.11 PCAS 6.11.1 PCAS Corporation Information 6.11.2 PCAS Small Molecule Active Pharmaceutical Ingredient Description and Business Overview 6.11.3 PCAS Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.11.4 PCAS Product Portfolio 6.11.5 PCAS Recent Developments/Updates 6.12 Patheon N.V. 6.12.1 Patheon N.V. Corporation Information 6.12.2 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Description and Business Overview 6.12.3 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Patheon N.V. Product Portfolio 6.12.5 Patheon N.V. Recent Developments/Updates 6.13 AstraZeneca 6.13.1 AstraZeneca Corporation Information 6.13.2 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Description and Business Overview 6.13.3 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.13.4 AstraZeneca Product Portfolio 6.13.5 AstraZeneca Recent Developments/Updates 6.14 Johnson & Johnson 6.14.1 Johnson & Johnson Corporation Information 6.14.2 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Description and Business Overview 6.14.3 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Johnson & Johnson Product Portfolio 6.14.5 Johnson & Johnson Recent Developments/Updates 6.15 Merck & Co 6.15.1 Merck & Co Corporation Information 6.15.2 Merck & Co Small Molecule Active Pharmaceutical Ingredient Description and Business Overview 6.15.3 Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Merck & Co Product Portfolio 6.15.5 Merck & Co Recent Developments/Updates 6.16 BASF SE 6.16.1 BASF SE Corporation Information 6.16.2 BASF SE Small Molecule Active Pharmaceutical Ingredient Description and Business Overview 6.16.3 BASF SE Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.16.4 BASF SE Product Portfolio 6.16.5 BASF SE Recent Developments/Updates 6.17 Catalent Inc. 6.17.1 Catalent Inc. Corporation Information 6.17.2 Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Description and Business Overview 6.17.3 Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.17.4 Catalent Inc. Product Portfolio 6.17.5 Catalent Inc. Recent Developments/Updates 6.18 Teva Pharmaceuticals 6.18.1 Teva Pharmaceuticals Corporation Information 6.18.2 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Description and Business Overview 6.18.3 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.18.4 Teva Pharmaceuticals Product Portfolio 6.18.5 Teva Pharmaceuticals Recent Developments/Updates 6.19 Roche 6.19.1 Roche Corporation Information 6.19.2 Roche Small Molecule Active Pharmaceutical Ingredient Description and Business Overview 6.19.3 Roche Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.19.4 Roche Product Portfolio 6.19.5 Roche Recent Developments/Updates 6.20 Cambrex Corporation 6.20.1 Cambrex Corporation Corporation Information 6.20.2 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Description and Business Overview 6.20.3 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.20.4 Cambrex Corporation Product Portfolio 6.20.5 Cambrex Corporation Recent Developments/Updates 6.21 GILEAD Science Inc. 6.21.1 GILEAD Science Inc. Corporation Information 6.21.2 GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Description and Business Overview 6.21.3 GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 6.21.4 GILEAD Science Inc. Product Portfolio 6.21.5 GILEAD Science Inc. Recent Developments/Updates 7 Small Molecule Active Pharmaceutical Ingredient Manufacturing Cost Analysis 7.1 Small Molecule Active Pharmaceutical Ingredient Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient 7.4 Small Molecule Active Pharmaceutical Ingredient Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Small Molecule Active Pharmaceutical Ingredient Distributors List 8.3 Small Molecule Active Pharmaceutical Ingredient Customers 9 Small Molecule Active Pharmaceutical Ingredient Market Dynamics 9.1 Small Molecule Active Pharmaceutical Ingredient Industry Trends 9.2 Small Molecule Active Pharmaceutical Ingredient Growth Drivers 9.3 Small Molecule Active Pharmaceutical Ingredient Market Challenges 9.4 Small Molecule Active Pharmaceutical Ingredient Market Restraints 10 Global Market Forecast 10.1 Small Molecule Active Pharmaceutical Ingredient Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Small Molecule Active Pharmaceutical Ingredient by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Small Molecule Active Pharmaceutical Ingredient by Type (2022-2027) 10.2 Small Molecule Active Pharmaceutical Ingredient Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Small Molecule Active Pharmaceutical Ingredient by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Small Molecule Active Pharmaceutical Ingredient by Application (2022-2027) 10.3 Small Molecule Active Pharmaceutical Ingredient Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Small Molecule Active Pharmaceutical Ingredient by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Small Molecule Active Pharmaceutical Ingredient by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) Comparison by Application (2021-2027) Table 3. Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Small Molecule Active Pharmaceutical Ingredient Covered in This Study Table 5. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) of Key Manufacturers (2016-2021) Table 6. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturers (2016-2021) Table 7. Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Small Molecule Active Pharmaceutical Ingredient Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Small Molecule Active Pharmaceutical Ingredient Manufacturing Sites and Area Served Table 11. Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type Table 12. Global Small Molecule Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Small Molecule Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Active Pharmaceutical Ingredient as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Small Molecule Active Pharmaceutical Ingredient Sales by Region (2016-2021) & (MT) Table 16. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2016-2021) Table 17. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Small Molecule Active Pharmaceutical Ingredient Sales by Country (2016-2021) & (MT) Table 19. North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2021) Table 20. North America Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2021) Table 22. Europe Small Molecule Active Pharmaceutical Ingredient Sales by Country (2016-2021) & (MT) Table 23. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2021) Table 24. Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Region (2016-2021) & (MT) Table 27. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region (2016-2021) Table 30. Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Country (2016-2021) & (MT) Table 31. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2021) Table 32. Latin America Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Country (2016-2021) & (MT) Table 35. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2021) Table 38. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2016-2021) Table 39. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2021) Table 40. Global Small Molecule Active Pharmaceutical Ingredient Revenue (Million US$) by Type (2016-2021) Table 41. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Type (2016-2021) Table 42. Global Small Molecule Active Pharmaceutical Ingredient Price (USD/MT) by Type (2016-2021) Table 43. Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2016-2021) Table 44. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2021) Table 45. Global Small Molecule Active Pharmaceutical Ingredient Revenue (Million US$) by Application (2016-2021) Table 46. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Application (2016-2021) Table 47. Global Small Molecule Active Pharmaceutical Ingredient Price (USD/MT) by Application (2016-2021) Table 48. Johnson Matthey Corporation Information Table 49. Johnson Matthey Description and Business Overview Table 50. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product Table 52. Johnson Matthey Recent Developments/Updates Table 53. Siegfried Holding AG Corporation Information Table 54. Siegfried Holding AG Description and Business Overview Table 55. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Product Table 57. Siegfried Holding AG Recent Developments/Updates Table 58. Pfizer Corporation Information Table 59. Pfizer Description and Business Overview Table 60. Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Pfizer Small Molecule Active Pharmaceutical Ingredient Product Table 62. Pfizer Recent Developments/Updates Table 63. Sanofi S.A. Corporation Information Table 64. Sanofi S.A. Description and Business Overview Table 65. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 66. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Product Table 67. Sanofi S.A. Recent Developments/Updates Table 68. Novartis AG, Corporation Information Table 69. Novartis AG, Description and Business Overview Table 70. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 71. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Product Table 72. Novartis AG, Recent Developments/Updates Table 73. Bristol-Myers Squibb Corporation Information Table 74. Bristol-Myers Squibb Description and Business Overview Table 75. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 76. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Product Table 77. Bristol-Myers Squibb Recent Developments/Updates Table 78. Boehringer Ingelheim GmbH Corporation Information Table 79. Boehringer Ingelheim GmbH Description and Business Overview Table 80. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 81. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Product Table 82. Boehringer Ingelheim GmbH Recent Developments/Updates Table 83. GlaxoSmithKline Corporation Information Table 84. GlaxoSmithKline Description and Business Overview Table 85. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 86. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Product Table 87. GlaxoSmithKline Recent Developments/Updates Table 88. Albany Molecular Research Inc. Corporation Information Table 89. Albany Molecular Research Inc. Description and Business Overview Table 90. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 91. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Product Table 92. Albany Molecular Research Inc. Recent Developments/Updates Table 93. Bachem Holding AG Corporation Information Table 94. Bachem Holding AG Description and Business Overview Table 95. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 96. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Product Table 97. Bachem Holding AG Recent Developments/Updates Table 98. PCAS Corporation Information Table 99. PCAS Description and Business Overview Table 100. PCAS Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 101. PCAS Small Molecule Active Pharmaceutical Ingredient Product Table 102. PCAS Recent Developments/Updates Table 103. Patheon N.V. Corporation Information Table 104. Patheon N.V. Description and Business Overview Table 105. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 106. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Product Table 107. Patheon N.V. Recent Developments/Updates Table 108. AstraZeneca Corporation Information Table 109. AstraZeneca Description and Business Overview Table 110. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 111. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Product Table 112. AstraZeneca Recent Developments/Updates Table 113. Johnson & Johnson Corporation Information Table 114. Johnson & Johnson Description and Business Overview Table 115. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 116. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Product Table 117. Johnson & Johnson Recent Developments/Updates Table 118. Merck & Co Corporation Information Table 119. Merck & Co Description and Business Overview Table 120. Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 121. Merck & Co Small Molecule Active Pharmaceutical Ingredient Product Table 122. Merck & Co Recent Developments/Updates Table 123. BASF SE Corporation Information Table 124. BASF SE Description and Business Overview Table 125. BASF SE Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 126. BASF SE Small Molecule Active Pharmaceutical Ingredient Product Table 127. BASF SE Recent Developments/Updates Table 128. Catalent Inc. Corporation Information Table 129. Catalent Inc. Description and Business Overview Table 130. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 131. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Product Table 132. Catalent Inc. Recent Developments/Updates Table 133. Teva Pharmaceuticals Corporation Information Table 134. Teva Pharmaceuticals Description and Business Overview Table 135. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 136. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Product Table 137. Teva Pharmaceuticals Recent Developments/Updates Table 138. Roche Corporation Information Table 139. Roche Description and Business Overview Table 140. Roche Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 141. Roche Small Molecule Active Pharmaceutical Ingredient Product Table 142. Roche Recent Developments/Updates Table 143. Cambrex Corporation Corporation Information Table 144. Cambrex Corporation Description and Business Overview Table 145. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 146. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Product Table 147. Cambrex Corporation Recent Developments/Updates Table 148. GILEAD Science Inc. Corporation Information Table 149. GILEAD Science Inc. Description and Business Overview Table 150. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 151. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Product Table 152. GILEAD Science Inc. Recent Developments/Updates Table 153. Production Base and Market Concentration Rate of Raw Material Table 154. Key Suppliers of Raw Materials Table 155. Small Molecule Active Pharmaceutical Ingredient Distributors List Table 156. Small Molecule Active Pharmaceutical Ingredient Customers List Table 157. Small Molecule Active Pharmaceutical Ingredient Market Trends Table 158. Small Molecule Active Pharmaceutical Ingredient Growth Drivers Table 159. Small Molecule Active Pharmaceutical Ingredient Market Restraints Table 160. Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Type (2022-2027) & (MT) Table 161. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Type (2022-2027) Table 162. Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Type (2022-2027) & (US$ Million) Table 163. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Type (2022-2027) Table 164. Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Application (2022-2027) & (MT) Table 165. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Application (2022-2027) Table 166. Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Application (2022-2027) & (US$ Million) Table 167. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Application (2022-2027) Table 168. Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Region (2022-2027) & (MT) Table 169. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Region (2022-2027) Table 170. Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Region (2022-2027) & (US$ Million) Table 171. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Region (2022-2027) Table 172. Research Programs/Design for This Report Table 173. Key Data Information from Secondary Sources Table 174. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Small Molecule Active Pharmaceutical Ingredient Figure 2. Global Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2020 & 2027 Figure 3. Standard API Product Picture Figure 4. High Potency API Product Picture Figure 5. Global Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2020 & 2027 Figure 6. Cardiovascular Diseases Figure 7. Respiratory Disorders Figure 8. Infectious Diseases Figure 9. Others Figure 10. Global Small Molecule Active Pharmaceutical Ingredient Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Small Molecule Active Pharmaceutical Ingredient Market Size 2016-2027 (US$ Million) Figure 12. Global Small Molecule Active Pharmaceutical Ingredient Sales 2016-2027 (MT) Figure 13. Global Small Molecule Active Pharmaceutical Ingredient Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturers in 2020 Figure 15. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Small Molecule Active Pharmaceutical Ingredient Players: Market Share by Revenue in 2020 Figure 17. Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2016-2021) Figure 19. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region in 2020 Figure 20. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region (2016-2021) Figure 21. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region in 2020 Figure 22. U.S. Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Taiwan Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Philippines Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Vietnam Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Mexico Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Brazil Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Argentina Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. U.A.E Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Small Molecule Active Pharmaceutical Ingredient by Type (2016-2021) Figure 47. Sales Market Share of Small Molecule Active Pharmaceutical Ingredient by Application (2016-2021) Figure 48. Sales Market Share of Small Molecule Active Pharmaceutical Ingredient by Application in 2020 Figure 49. Revenue Share of Small Molecule Active Pharmaceutical Ingredient by Application (2016-2021) Figure 50. Revenue Share of Small Molecule Active Pharmaceutical Ingredient by Application in 2020 Figure 51. Manufacturing Cost Structure of Small Molecule Active Pharmaceutical Ingredient Figure 52. Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient Figure 53. Small Molecule Active Pharmaceutical Ingredient Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Johnson Matthey Siegfried Holding AG Pfizer Sanofi S.A. Novartis AG, Bristol-Myers Squibb Boehringer Ingelheim GmbH GlaxoSmithKline Albany Molecular Research Inc. Bachem Holding AG PCAS Patheon N.V. AstraZeneca Johnson & Johnson Merck & Co BASF SE Catalent Inc. Teva Pharmaceuticals Roche Cambrex Corporation GILEAD Science Inc.